PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,878 stories, page 572 of 732

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Tarsus pays $75M for eye drug candidate with Phase 3 ahead

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI as Reinvention | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RSV Antiviral Zelicapavir Enters Late-stage Clinical Trials

respiratory-therapy.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Merger Tests AI Patient Stratification Against RA’s 70% Treatment Gap

Tech TimesOriginal source
🇮🇹Industryrecordati.comTier 1 · Company source

On behalf of Respighi BidCo S.p.A – CONSOB approved the Offer Document

RecordatiOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Global clinical trial launches to test self-given, long-acting gMG drug

Myasthenia Gravis NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ai-Generated Drug Rentosertib Trialed for Idiopathic Pulmonary Fibrosis

respiratory-therapy.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Major biotech company laying off 103 more employees in fifth round of cuts since mid-2025

MassLiveOriginal source
🇫🇷Industrypierre-fabre.comTier 1 · Company source

Les Laboratoires Pierre Fabre augmentent leur participation au capital de MiYé pour accélérer son développement en pharmacies

Pierre FabreOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA collects ghee, honey samples during inspection

Pioneer EdgeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Scoop to soup: FDA freezes licence of Mumbai's iconic ice cream outlet after rats found on premises

The Economic TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DEA Proposes Schedule I Ban for the First “Gas Station Drug," Tianeptine

FilterOriginal source
🌍discoverynews.google.comTier 2 · Trade media

FDA halts release of new drug rejection letters while working to formalize policy

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Errant FDA Policy and Dramatic Rise of Device and Drug Recalls : News Article

Independent InstituteOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Powering scientific discovery: BYOKG and GraphRAG for intelligent pharmaceutical research

Amazon Web Services (AWS)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical company to build rare manufacturing facility in Sugar Land

KHOUOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Campylobacter infection: annual data

Annual data of reported Campylobacter infections in England since 2006.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

AstraZeneca, GSK intensify China ties with Sino Biopharm deals

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA suspends licence of iconic Mumbai ice cream outlet K Rustom over food safety violations

The Indian ExpressOriginal source
🇺🇸Devicesbtig.comTier 1 · Company source

BTIG Expands Energy and Infrastructure Investment Banking Coverage with the Addition of Michael Bodino and Chris Gibson

BTIGOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Keenova Therapeutics Reports Positive Phase 3 XIAFLEX Data

grafa.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Regulatory update on the 2026 Drugs to Watch

ClarivateOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sana Biotech heads to EASD with diabetes cell therapy update

Longevity.TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?

Insider MonkeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Community pharmacy could help ease £2.7bn delayed discharge bill

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Europe will accelerate its review of RevMed’s drug

STATOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

FDA cracks down on illegal ketamine sellers amid nearing ‘psychedelic revolution’

Pharmaceutical TechnologyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 51 report: data to week 50 (data up to 13 December 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 50 report: data to week 49 (data up to 6 December 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Satellos’ ‘intriguing’ Duchenne data raise hopes ahead of key readout

Fierce BiotechOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 49 report: data to week 48 (data up to 29 November 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 48 report: data to week 47 (data up to 22 November 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 47 report: data to week 46 (data up to 15 November 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Is Satellos Bioscience Trading Higher Today? - Satellos Bioscience (NASDAQ:MSLE)

BenzingaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Deanna Horner's Five-Year Outlook for Direct-to-Patient Care

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Growth Trust: The biotech rebound powered by innovation, valuations and pharma’s patent cliff

DirectorsTalk InterviewsOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Looking after children and those in early years settings before and during hot weather: teachers and other educational professionals

This page advises those working with children on how to reduce the risks of hot weather to the healt...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DeliverIt to build $12M pharmaceutical manufacturing facility in Sugar Land

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Completes Share Issuance, Disposal Under Incentive Plan

MoomooOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sanner Group

businessfocusmagazine.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Next Generation of Medicine: Personalized, Preventive, and Powered by Technology

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain

Yahoo! Finance CanadaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vaccinex to show new Alzheimer’s biomarker data in London

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Diluted earnings per share (diluted EPS) of Veraxa Biotech AG – NASDAQ:VRXAW

TradingViewOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

10 Year Capital Plan for Health and Social Care

Details the government’s plan for capital investment to transform healthcare infrastructure over the...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What is the Multi Billion Dollar UK-US Pharmaceutical Deal?

Healthcare DigitalOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Two lots of Omnitrope injectable human growth hormone recalled due to cracked cartridges

Sandoz Canada Inc. is recalling two lots of Omnitrope 5 mg/1.5 mL somatropin after receiving complai...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Allura Xper FD10

Philips has identified through customer complaints that, during certain repair or service actions, H...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Alice Le System - Sleepware Software

Philips Respironics has become aware of a compliance issue with Sleepware G3 versions 4.0.0.0 and ab...

Health Canada Recalls and Safety AlertsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Joincare Pharmaceutical Group Industry Co., Ltd. Sponsored GDR Class A RegS

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Japan's Tanabe sells Pharma Factory to Towa Pharmaceutical

BioSpectrum AsiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ananda Pharma Confirms Safety of MRX1 CBD Drug, as Clinical Pain Trials Approach

Business of CannabisOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Pharmaceutical Technology

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma receives FDA feedback on phase 3 neuropathic pain trial

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

From Semis to Biotech: A Market Rotation, Not an AI Reversal

MoomooOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chemomab, Scipher tie merger to AI-guided rheumatoid arthritis trial

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Immunome Announces U.S. FDA Acceptance of New Drug Application for Varegacestat for the Treatment of Adults with Desmoid Tumors

Business WireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors

The Manila TimesOriginal source